Dog Aging Science: Longevity Research and Senior Welfare

Dog aging research is advancing rapidly, with projects studying longevity factors and age-related diseases. Understanding the science of canine aging helps owners support their senior dogs through healthy final years.

Key Facts

The Dog Aging Project is a large-scale longitudinal study examining health, environment, and longevity in thousands of US dogs.
Rapamycin, an mTOR inhibitor, has shown promise in extending lifespan and improving cardiac function in aging dogs.
Larger dog breeds age faster and have shorter lifespans than smaller breeds — giant breeds may age 15 times faster.
The TRIAD score — Tumor, Renal, Arthritis, Idiopathic disease — predicts senior dog welfare and survival.
Cognitive dysfunction syndrome, arthritis, and cancer account for the majority of welfare decline in dogs over age 10.

Welfare Considerations

Senior dog welfare requires proactive management of age-related changes in mobility, cognition, sensory function, and disease burden. Dogs do not reliably communicate pain or reduced function to owners, meaning that welfare decline in senior dogs is frequently undetected until it is severe. Annual senior wellness visits with blood panels, mobility assessment, and quality-of-life scoring enable early detection and intervention. Advances in canine longevity research may significantly extend healthy lifespans, but the immediate welfare priority is ensuring that all senior dogs receive appropriate pain management and quality-of-life monitoring.

What You Can Do

Schedule biannual veterinary wellness visits for dogs over age 7.
Use validated quality-of-life assessment tools to monitor your senior dog regularly.
Ask your vet about pain management options for age-related arthritis.
Consider enrolling your dog in the Dog Aging Project for longitudinal research.
Learn about cognitive dysfunction syndrome — early recognition enables earlier treatment.